Feasibility study highlights an unmet need of patients receiving palliative radiotherapy for bone metastases pain, but the intervention was not as feasible for staff.
A mouse xenograft model of DLBCL tumors was used to characterize the role of TNFAIP3 expression tumor growth. Tumors induced from cells with higher levels of TNFAIP3 had a lower volume compared with ...
Using sarcoma organoids, researchers were able to identify “active, approved, or recommended therapies” for 58% of patients screened. “We’ve shown that it’s possible to generate sarcoma organoids ...
The median progression-free survival was 9.6 months in patients who received site-specific therapy and 6.6 months in patients who received empirical chemotherapy. Patients diagnosed with cancer of ...